Characterization of the dystrophin-syntrophin interaction using the two-hybrid system in yeast  by Castelló, Anna et al.
FEBS Letters 383 (1996) 124-128 
Characterization of the dystrophin-syntrophin i teraction 
two-hybrid system in yeast 
FEBS 16828 
using the 
Anna Castell6, Val6rie Broch6riou, Philippe Chafey, Axel Kahn, H616ne Gilgenkrantz* 
U. 129 INSERM, lnstitut Cochin de GOnOtique Molbculaire, 24 rue du Fbg St. Jacques, 75014 Paris, France 
Received 15 January 1996 
Abstract The carboxy-terminal region of dystrophin has 
previously been shown to interact directly with a l  syntrophin, 
a cytoplasmic component of the dystrophin-glycoprotein com- 
plex, by in vitro biochemical studies such as overlay assay or 
immunoprecipitation. Using the two-hybrid system, we have 
isolated from a human heart cDNA library the entire coding 
sequence of human ~I syntrophin, therefore confirming for the 
first time this interaction via an in vivo approach. In addition, we 
have reduced the interaction domain to the distal half of ~1 
syntrophin. 
Key words: Protein-protein teraction; 59 DAP; Duchenne 
muscular dystrophy 
1. Introduction 
Dystrophin, the protein product of the Duchenne muscular 
dystrophy gene, is thought to link the cytoskeleton to the 
extracellular matrix in skeletal muscle through a glycoprotein 
complex (DGC). This DGC is composed of at least five sar- 
colemmal glycoproteins (~ and 13 dystroglycans, ct, 13, and y 
sarcoglycans) and intracellular proteins belonging to the same 
family: syntrophins [1-4]. Syntrophins are a heterogeneous 
group of phosphorylated 58-59 kDa proteins encoded by at 
least three different genes which are classified in acidic (ct) and 
basic ([~) components and show a different expression pattern 
[5]. Alpha-1 syntrophin, which has been cloned in mouse [6] 
and rabbit [7], is abundantly expressed in skeletal muscle. 
Beta-1 syntrophin, which has been isolated in human, is ubi- 
quitously expressed but at lower levels in brain and heart than 
in other tissues [8]. Finally, 132 syntrophin, cloned in mouse 
and only partially in human [5,8], is expressed at low levels in 
numerous tissues but seems to be especially concentrated at 
the neuromuscular junction in muscle [9]. 
Among DGC proteins, only syntrophins and 1~ dystrogly- 
can have been involved in direct interactions [10,11] with the 
carboxy-terminus of dystrophin or with an isoform of dystro- 
phin encoding only the last two domains from exon 63 to 79, 
namely apodystrophin 1 [10]. Binding sites have been localized 
within residues 3445 3494 of human dystrophin for mouse txl 
syntrophin and within residues 3495-3544 for 131 syntrophin 
by overlay assays with fusion proteins [12] or by co-immuno- 
precipitation with in vitro translated proteins [13]. However, 
no in vivo assay has ever demonstrated this interaction. As 
dystrophin shows a distinct subcellular localization in heart 
and skeletal muscle, it has been suggested that it could play 
different roles in these two tissues, potentially by different 
protein-protein interactions. We have therefore screened a 
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human heart cDNA library using the two-hybrid system in 
order to look for new partners of dystrophin or of its more 
distal isoform, apodystrophin 1. Using a bait covering exon 
64 to 75 (but deleted of exon 71), we have identified among 
positive clones several ones coding for a human ct syntrophin, 
very homologous to mouse and rabbit etl syntrophins. 
2. Material and methods 
2.1. Two-hybrid constructs 
Human dystrophin carboxy-terminus encoding residues 3103-3549 
was generated by polymerase chain reaction on the full length dystro- 
phin cDNA deleted of exon 71 and kindly provided by M. Koenig 
(lllkirch, France), using the following forward and reverse oligonu- 
cleotides with incorporated restriction sites: 64 ID EcoRI: 5' CGG 
AAT TCT CAG CTT ATA GG 3' and 75 CT XhoI: 5' CCG CTC 
GAG AGG TGG GCA TCA 3'. The amplified product was cloned 
into the EcoRI/SalI sites of pGBT9 plasmid (Clontech) containing 
Gal4 binding domain downstream from the Saccharomyces cerevisiae 
ADH1 constitutive promoter and the resulting construct was called 
pGBT9-3. The insertion was entirely sequenced using dideoxyNTPs 
and sequenase 2.0 according to the manufacturer's specification (U.S. 
Biochemical). The background of this construct was appreciated by 
co-transformation with control plasmids containing the Gal4 tran- 
scriptional activation domain (Gal4AD) alone as pGAD424 (Clon- 
tech), or with an in phase cDNA such as those for Snif4 [14] or 
Raf [15] in HF7c yeast strain: Mat a, ura 3-52, his 3-200, ade2-101, 
1ys2-801, trpl-901, leu2-3, 112, ga14-542, ga180-538, ura3 : ." Gal4 bind- 
ing sites-CYC1-LacZ, lys2::Gall-His3. No background for I~-galacto- 
sidase activity was obtained after overnight incubation at 30°C or for 
histidine xpression after 5 days at 30°C on selective medium lacking 
tryptophan, leucine and histidine and supplemented with 15 mM 3- 
amino-l,2,4-triazole (3AT) for all double-transformants. 
2.2. Library screening 
HF7c yeast strain already transformed with pGBT9-3 plasmid, 
which contains a tryptophan (TRP1) marker, was transformed with 
250 ktg DNA of a commercial human heart cDNA library cloned into 
plasmid pGAD10 (Clontech), which contains the Gal4 activation do- 
main and a leucine (LEU) auxotrophic marker using the already de- 
scribed lithium acetate method [16]. 
350 000 transformants were plated on selection plates lacking tryp- 
tophan, leucine and histidine and supplemented with 15 mM 3AT. 
After 12 days, colonies grown on this selective medium were repli- 
cated on Whatman paper (no. 40). After overnight incubation at 
30°C, these filters were immersed in liquid nitrogen for a few seconds 
and layered on Whatman paper (no. 3) humidified with 3 ml of Z 
buffer and incubated at 30°C. Z buffer contains 60 mM Na2HPO4, 40 
mM NaH2PO4, 10 mM KC1, 1 mM MgSO4, 30 mM 13-mercaptoetha- 
nol and 5-bromo-4 chloroindolyl-13-D-galactoside (XGal) at a final 
c'oncentration f 0.2 mg/ml. 
2.3. Rescue of positive plasmids 
To rescue GaI4AD fusion plasmids, total yeast DNA was isolated 
according to the method of Hoffman and Winston [17]. To avoid 
waste of time in this step, 96 different DNA preparations were placed 
in 96 well microplates and analyzed by pooling DNAs from each of 
the 8 rows and 12 columns. Each of these 20 pools was then used to 
directly electroporate E. coli HB101 as recommended in the Bio-Rad 
user's guide. This step allows one to eliminate the Gal4 DNA-binding 
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Fig. 1. Histidine and I~-galactosidase expression of interacting dystrophin and otl syntrophin clones.Two independant clones were patched and 
aliowed to grow on selective medium (depleted in tryptophane and leucine) for each co-transformation a d replicated either on a filter for 
LcZ activity or on a medium lacking also histidine and containing 15 mM 3AT for histidine xpression. The co-transformed plasmids are indi- 
cated above and on the side for each co-transformation. S ifl/Snif4 and Ras/Raf are positive controls of strong interactive proteins. Only the 
c(,-transformants pGBT9-3/5B, pGBT9-3/4D and pGBT9-3/5B3 grow on selective medium and show LacZ activity. A schematic representation 
o; clones 5B, 5B1, 5B2 and 5B3 is indicated below with the location of BgllI sites and the initiation and stop codons. 
ptasmid in M9 medium supplemented with ampicillin because HB101 
strain has a defect in the leuB gene, which can be complemented by 
L,~U2 from yeast harbored by the Gal4AD plasmid. M9 medium 
ct~ntains M9 minimal salts 1% (w/v), glucose 0.4% (w/v), NaCI 
05%0 (w/v), proline 0.1%0 (w/v), Bacto-agar 1.5% (w/v), thiamine 
1 raM, MgSO4 2 mM. 
2 ~. Subcloning of syntrophin plasmids 
The EcoRI/BgllI 0.45 kb fragment of clone 5B was subcloned in 
pGAD424 plasmid, which has been digested with EcoRI and BamHI, 
st, that the syntrophin fragment was in phase with Gal4AD, giving the 
5B1 construct. After a BgllI digestion of clone 5B, fragments of 0.4 
aT~d 0.85 kb were subcloned in pGAD424 digested with BamHI, giv- 
ing clone 5B2 and 5B3, respectively. These 3 plasmids were co-trans- 
firmed in Hf7c with the same specific (pGBT9-3) and non-specific 
plasmids (Gal4 DNA-binding domain fused to non-specific cDNAs) 
aad colonies were allowed to grow on selective medium and tested for 
1_ ~cZ activity. 
3 Results 
To search for cDNA clones encoding proteins that interact 
u ith the carboxy-terminal part of dystrophin, we used the 
t,vo-hybrid system for detection of protein-protein interaction 
i~ yeast [18]. The HF7c yeast strain used for the screen har- 
bors integrated LacZ and HIS3 gene under the control of 
(;a14 multimerized sites and Gall promoter, respectively. 
q hese marker genes become transcriptionally active only if a 
fanctional trans-activator binds on these promoter sites. 
As bait, we created a chimeric plasmid, pGBT9-3, which 
contains amino acids 3103-3549 but deleted of amino acids 
3409-3421 of the dystrophin sequence, fused in frame to the 
(;a14 DNA-binding domain (Gal4DBD). 
We first verified that pGBT9-3 lacked transcriptional activ- 
ity on its own by co-transforming the HF7c yeast strain with 
this vector and control vectors containing the GaI4AD alone 
(pGAD424, Clontech) or fused in phase with different cDNAs 
as Raf or Snif4 cDNAs. 
To identify cDNA clones encoding proteins that interacted 
with dystrophin, we transformed the above yeast strain with 
pGBT9-3 and a human heart cDNA library in which the 
oligo(dT) and random primed cDNAs (mean size 1.7 kb) 
were fused to the Gal4AD. 
Screening 350 000 independent transformants for activation 
of the LacZ and histidine markers yielded 640 colonies that 
stained for [5-galactosidase activity between 2 h and an over- 
night 30°C incubation. 
Two frequent problems encountered in two-hybrid assays 
are to isolate positive clones in the original cDNA screen that 
turn out not to be confirmed after purification of the isolated 
plasmid, or not to be specific. To determine whether activa- 
tion of the marker genes reflected a specific interaction, and in 
order to accelerate this time-consuming step when numerous 
clones have been isolated in the first screening, each eDNA 
clone was rescued from yeast and 96 DNAs were pooled in 
series of 12 and 8 DNAs (see section 2). Each pool of DNAs 
was used to electroporate E. coli HB101, allowing us to per- 
form only 20 electroporations i stead of 96. A miniprepara- 
tion of plasmid DNA was performed after a 2 day liquid 
culture in M9 medium at 37°C (Wizard kit, Promega) and 
the DNA obtained was retransformed into the same HF7c 
yeast strain, either with the original bait pGBT9-3, or with 
different control plasmid in which the Gal4 DBD is alone 
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(pGBT9-) or fused to a non-specific DNA such as those for 
p53 [19] of Snif 1 [14] which are not expected to interact with 
dystrophin. These transformed yeasts were directly spotted 
onto selective medium depleted of tryptophan and leucine. 
Grown spots were tested for LacZ and histidine activity. 
On the first 192 tested plasmids collected in 40 pools, 4 
pools (4, 5, B, D) corresponding to 2 columns and 2 rows 
stained intensely for 13-galactosidase activity within 1 h and 
grew on selective medium lacking tryptophan, leucine and 
histidine and supplemented with 15 mM 3AT in 48 h, only 
with the original bait and not with negative control plasmids. 
Three other pools showed LacZ activity after more than 4 h. 
We therefore decided to focus on the 4 earlier positive pools. 
Crossing yeast DNA plasmids between positive rows and col- 
umns (clones 5B, 4D) were retransformed into HF7c with the 
different negative controls. Both showed the same histidine 
and LacZ expression pattern as the corresponding pools 
(Fig. 1). 
To determine whether clones 5B and 4D might represent 
previously identified proteins, we sequenced the 5'-and 3'-ends 
of the cDNA and searched with fasta and blast algorithms in 
the database for amino acid and nucleotide homologies. Both 
clones showed a strong homology with rabbit and mouse ctl 
syntrophins (Fig. 2). 5B and 4D clones were entirely se- 
quenced and showed differences only in their 5'-non-coding 
extremity (after 14 common 5'-nucleotides, clone 4D shows a 
72 nucleotide long DNA stretch, homologous to rabbit syn- 
trophin, which is not present in clone 5B; afterwards both 
A 
4D ~ ~  -46 
AAGCGGC-ACA ATG GCG TCC GGC AGG CCG GCC CL-X~ CGC ACC 30 
M A S G R P A P R T 
GGG CTG CTG GAG CTG CGC GCC GGGGC~ GGC qL~G GGGGCC GGC GCGC~GCGA TGG CAG CGGGTG CCT 96 
G L L E L R A G A G S G A G A E R W Q R V P 
GTG AGT CTG GCG GAG GAC GTG CTG ACC GTG AGC ~ GCC GAC GGC GAC CCT GOlf CCC GAG CCC GGC 162 
V S L A E D V L T V S P A D G D P G P E P G 
GCT CCG CGG GAG CAG GAG CCC GCG CAG CTC AAC GAC GCC GCG GAG CCG GGC GC~ GGG CCC CCG CAG 228 
A P R E Q E P A Q L N D A A E P G A G P P Q 
CTG CCA GAG GCG CTA CTG CTC CAG CGG CGC CGC GTG ACG GTG CGC AAG GCC GAC GCC GGT'GGG CI~ 294 
L P E A L L L Q R R R V T V R K A D A G G L 
GGC ATC AGC ATC AAA GGC GGC CGG GAG AAC AAG ATG CC~ ATT CTC ATT TCC AAG ATC ~ AAG GGA 360 
G G R E N K M P I L I S K I F K G 
ACA GAG GCC CTT TIT GTG GGG GAT GCC ATC CTG qL~f GTG AAT GGG GAA GAC 426 
T E A L F V G D A I L S V N G E D 
CAT GAT GAG GCG GTG CAG GTC CTC AAG AAG ACA GGC A~/~ GAG GTG GTG CTG 492 
H D E A V Q V L K K T G K E V V L 
AAG GAC GTC TCA ~ TAT TIC AAG AAC ~ ACT GGT GGG ACC TCG GTC GGC 558 
K D V S P Y F K N S T G G T S V G 
GCC TCA ~ CTT CAG CGG CAG CC~ TCC qL~C CCT GGC CC~ ACA CC~ CGG AAC 624 
A S P L Q R Q P S S P G P T P R N 
CAC ATG TCC TTG AAG ATG GCA TAT GTC TCG A~3 AGG TGC ACC CCC AAT GAC 690 
H M S L K M A Y V S K R C T P N D 
G I S I K 
CTG GCA GCT GAC CAG 
L A A D Q 
TTG TCC TCT GCT ACC 
L S S A T 
GAG GTC AAG TAT ATG 
E V K Y M 
TGG GAC TCA CCT CCT 
W D S P P 
TTC AGC GAG GCC AAA 
F S E A K 
CCG GAG CCC AGG TAT 
P E P R Y 
GAT GAG GCT ~T GCG 
D E A S A 
GTC AAG GAT GA~3 CTG 
V K D E L 
ATT G~C TGG CTA ACT 
I G W L T 
AAG GAA CTG CTC CI~ 
K E L L L 
GCC CCA CTC ATC GCC 
A P L I A 
GAG CTC qL-'f TIT GCC 
E L S F A 
TCA CC~ CAG GAG CTG 
S P Q E L 
GTG C~3 GAG G'I~3 TCT 
V Q E V S 
AAG GGC TTC ACA CTG 
K G F T L 
GAG AAG CTG CAG ATG 
E K L Q M 
CTG GAG ATC TGC TCG GCA GAT GGT CAA GAC ACC CTC TTC CTG AGG GCC AAG 756 
L E I C S A D G Q D T L F L R A K 
~ qL~G '1-O3 GCG ACT GCC ATC CAA GCC CAG GTC AAT ACT CTG ACG ~ CGG 822 
R S W A T A I Q A Q V N T L T P R 
CAG GCA CTG TTG GCA ~ ACC ~C ACA GCT GGG AGC CAG GAC ATC AAG CAG 888 
Q A L L A A T S T A G S Q D I K Q 
GAG CAG CTG CCC AGT GGG GGC ACA GCC CCC ACC CYG C4L~ CTG CTA ACT GAA 954 
E Q L P S G G T A P T L A L L T E 
TAC TIG TCT CTC CC~ GAG ACC CGC GAG GCC CTG AGC CGG CCA GCC CGT ACT 1020 
Y L S L P E T R E A L S R P A R T 
ACC AGA ~ GTG CAC TCA GGC CC~ TCC AAG GGC TCA GTG CC~ TAC GAT GCA 1086 
T R L V H S G P S K G S V P Y D A 
CTG CGC ACG GGC ACG CGT CAC GGT GTG GAC ACT CAC CTG TTC ~f~C GTG GAG 1152 
L R T G T R H G V D T H L F S V E 
GCT GCC TGG ACC CGC C~3 CTT G~fG GAT GGC q~T CAC CGG GCC GCC GAG GGT 1218 
A A W T R Q L V D G C H R A A E G 
ACA GCC TGC ACG TGG AAT GGG CGT CCX~ TGC AGC CTG TCT GTG CAC ATC GAC 1284 
T A C T W N G R P C S L S V H I D 
TGGGCG GCT GAGCCA~- 'TGCAGCC CGAGCT GTG CTC CTG ~CAG CCC TTC 1350 
W A A E P G A A R A V L L R Q P F 
qL~f TCA GAT GAC GGT GC~ AGT CTC CIT TTC CTG GAT TIT GGA GGT GCT GAA 1416 
S S D D G A S L L F L D F G G A E 
GGC GAG ATC CAG CTG GAC CTG CAC TCG TGT CCC AAA ACC ATA GTC TTC ATC ATC CAC TCC TTC CTG 1482 
G E I Q L D L H S C P K T I V F I I H S F L 
GCC AAA GTC ACC CGC CTC GGG CTG TTG C~ TAG ~ T G C A C T  1557 
S A K V T R L G L L A 
TGACA _ ~ 1642 
Fig. 2. (A) Nucleotide sequence and predicted open reading frame of human txl syntrophin. Nucleotide sequence of clone 4D. The positions of 
the nucleotides are indicated on the right from the first translated nucleotide. BglII sites corresponding respectively to the end of clone 5B1 and 
beginning of clone 5B2 for the first one and the end of clone 5B2 and beginning of clone 5B3 are in bold. The predicted amino acid sequence 
is indicated in single-letter amino acid code. (B) Alignment of the amino acid sequence of human, rabbit and mouse ctl syntrophins. The amino 
acid sequence of the corresponding proteins indicated on the right is shown in single letter amino acid code. Identical residues between two con- 
secutive sequences are indicated by a bar, while similarity is indicated by two points. 
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1 MAS(~:~P.~,/:~.'I-C-. -,T ,T ,k'~T RAC~RVI rCSLA I~I )VLTVSPADGDPG human 
lilll llllllllllll I lll:illlll iillll IIIIIIII:II 
1 MASGRRAPRTGT.T,~ ~ R V L ~ T V S P A D G E P G  rabbit 
1111111111111111 I I lllllllllll:lllllilllllllllll 
1 MASGRRAPR~T.T , I~T/EC~~TVSPADGEIX3  mouse 
51 PE~EP~~PPQLPE~T.T  T QRRRVI'4BKAIX~X~GI human 
IIIII II llil:l:llllil:lliillltlllllllllllllllllll 
51 PEPGAVREPEPAQ~PQLPF_~T,T ,TQ I rabbit 
III 1111:lilllilllllllllllllllllllllillllllil 
51 PEP EPAQ~PQ~T,T ,TQ LGI mouse 
i01 S I K ~ I L I S K I ~ ~ L S S A T H D E  human 
IL1111111111111LllilItll111111Llli1111IliIL1111hll 
i01 S IK~IL ISK I~LSVNr=EDLSSATHDE rabbit 
llIIllIlliLllllllllllilllllllllllllLllllllllilllll 
95 S I K ~ I L I S K I ~ ~ E D L S S A T H D E  mouse 
l s l  A " " v ,m~s~~Pnsvr_~Q~ h ~  
liB I I I I I I I I I l i l l l l l : l l l l l l l l  I I I I I I l i l l l l l l l l l l i l  
151 ~ g ~ a ~ s ~ s v ~ , ~ p P n s z ~ v s  ra~i t  
I I I l l l l l l l l l i l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l i l l l  
147 ~PYFKNSAGGT~PPASPr__QRQPS mouse 
201 SPGPTPRNFSEAKHMSLKMAYVSKRcI'~IqDPEPRYLEICSADGQDTLFI/~ human 
IIII 11:1111]: lllilll:llll III LIIIIIIIIIIII:III 
201 SPGP~EAKHVPIZMAYVSRRCTPSDPI~IR~CSAI~DTIF I /R .  rabbit 
lllli 111111111 illlllliilll III TIILII lllli :ill 
197 SPGPQ YVSRR~PEPRY IZ~ICAA~DAVFI /~ mouse 
llllllillll Lllli:l I i:lllllllllll I ililllllllll 
251 AKDEASARSIgB~AIQAQ~SPAGSQDIKQIGWL rabbit 
llilllllllllllllll ::lllllilllll I : IIIIIIIIIIII 
245 ~QAQIGTF IPWVKDELQALLTAgGT/~.SQDIKQIGWL mouse 
301 ' I "EQLI: :>Sf~-'TAP' I"LA[. J~ ,T ,T ,~LP~A.RTA_PL  IAT  h ~  
illlllllllillillllllllll :II:IIIIIIIIIIIIIIIII 
301 TEQLPS([IGTAPILALLTEK~ ,T .T .YGG~ARTAPL IAT  rabbit 
lilillillllllllllllilI:l :III illLlil illlllil 
295 TEQLPSGG~A_DTIICLTI~<k-~,r.RYCSLPQ~TAPLIATSSAH mouse 
347 RLVHSGPSKGSVPYDART ~qFALRq~-TRHGVI)IS{LFSVESPQEI2kAWI~QL 
ILIIIIIIIIIIIIIIIIIIBLIIIIIIIIIIIIIIIIIIIIIIIIIIII 
347 RLVHSGPSKGSVPYDAk~.qFAI/~TGTRHGVI)I'HLFSVESPQELAAWTRQL rabbit 
IIIIIIIIIIIIIIIIIII111111111111iliiiii111111111111 
345 RLVHSGPSK~FAIa~TGTRH~S"4F~PQ~QL mOuse 
I I I I I I I I I I l l l l l l l l l l l  I I I I I I I I l l l l l l l l l l l l l l l l l l l l  
397 V ~ E V S T A  E g K ~ r ~ V L L  rabbit 
llililllll:llllllllllllli lllllllllllilllllilll:ll 
395 V[X IK} IRAA]K~IQEVS~~SISVHI~ mouse 
lllllllllilll1111111111illillllllll:lllilll1111111 
447 RQPFEKI~SD~LLFI/)bX~?~kIK]~IQLDLKSCPK"IMVFIIHSFLSA rabbit 
11111111111111 lllllllLilllllllllllllilllllLllllll 
445 RQPFEKLQMSSDDG~SLLFLDFGGAIKZ~IQLDT_h{SCPKTMVFIIHSFLSA mouse 
497 ~/~T,?A  505 htm~an 
IIIIIIIII 
497 }CVTRLr~T.TA 505 rabbit 
IIIIiii11 
495 KVTRI_GI/Ak 503 mouse 
Fig. 2. Continued. 
sequences are identical). Human syntrophin sequence shows 
95.84% similarity and 92.87% identity with rabbit ctl syntro- 
phin at the amino acid level and 89.28% identity at the nu- 
cleotide level. 
To investigate further the interaction between human dys- 
trophin and human ~1 syntrophin, we subcloned clone 5B 
into three parts. Before having the entire sequence of clones 
5B and 4D, we first verified that some restriction sites were 
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conserved between rabbit and human. Among BgllI, PstI and 
PvulI enzymes, used to digest clone 5B, only BgllI gave the 
expected profile, according to the rabbit sequence. We there- 
fore subcloned the 3 restriction fragments obtained with BgllI 
in pGAD424 plasmid in the same phase as mouse and rabbit 
ctl syntrophins. These 3 subclones (5B1, 5B2, 5B3) were tested 
for their interaction with dystrophin in the two-hybrid system. 
Only clone 5B3, corresponding to the last 268 amino acids out 
of the 505 residues of human syntrophin, allows for activation 
of the reporter histidine and LacZ genes (Fig. 1). 
4. Discussion 
The syntrophin family is a heterogeneous group of at least 
three isoforms encoded on three distinct genes. They are all 
expressed in a wide variety of tissues, but ctl and ~1 syntro- 
phins for example show, in the same tissue, a segregated sub- 
cellular distribution. Immunoaffinity isolation of syntrophin 
from a variety of rat tissues has shown that dystrophin, 
Dp71 or apodystrophinl and utrophin are able to copurify 
with syntrophins [10]. Most of the experiments showing direct 
interaction between dystrophin or its distal isoforms and the 
different members of the syntrophin family have used immu- 
noprecipitation of in vitro translated proteins, or overlay as- 
says with skeletal muscle extracts [6,12,13]. We have con- 
firmed this interaction between dystrophin and c~l 
syntrophin in heart by demonstrating an in vivo interaction 
in yeast using the two-hybrid system. Moreover, using a trun- 
cated carboxy-terminal sequence of dystrophin as bait, we 
have isolated the syntrophin partner among a human heart 
cDNA library. 
Previous studies have located the syntrophin binding sites 
on the dystrophin sequence to amino acids 3445-3494 for ctl 
syntrophin and amino acids 3495-3535 for [31 syntrophin and 
have suggested that the flanking region (amino acids 3536 to 
3685) also contributes to the stable binding to syntrophin [12]. 
The dystrophin bait we used ends at residue 3549 and shows 
strong activation of the reporter gene, suggesting it is, how- 
ever, sufficient o interact with syntrophin. By immunopreci- 
pitation with in vitro translated fusion proteins, Ahn and 
Kunkel [13] showed that the interacting region of 131 syntro- 
phin was carried by its carboxy-terminal half (last 335 amino 
acids of the 537 residues of 131 syntrophin). Accordingly, we 
demonstrate in this paper that the carboxy-terminal half of ctl 
syntrophin, 53% homologous with ~1 syntrophin, also inter- 
acts with dystrophin. 
The human coding sequence of ctl syntrophin was not 
known previously. As expected, it exhibits a strong sequence 
conservation with rabbit and mouse ct syntrophins. The syn- 
trophin txl gene has been recently located on human chromo- 
some 20 by Froehner's group [20], who also describes four 
conserved omains in the syntrophin family members: two 
pleckstrin homology domains, found in many proteins in- 
volved in intracellular signalling, a PDZ domain (for post 
synaptic density protein-95, Drosophila disc large tumor sup- 
pressor protein, zonula occludens-1 protein) and a carboxy- 
terminal 56 amino acid domain, highly conserved among spe- 
cies and isoforms and showing no homology with other pro- 
teins [20]. The PDZ domain contains a GLG(F/I) sequence, 
which is present in a heterogeneous family of signalling pro- 
teins localized to specialized cell-cell junctions; the GLG(F/I) 
motif has also been found in nitric oxide synthase protein 
(NOS), a protein recently shown to be complexed with dys- 
trophin and abnormally localized in mdx mouse and Duch- 
enne patients' sarcolemma [21]. The PDZ domain of human 
txl syntrophin is entirely contained in the 5B1 and 5B2 con- 
structs, with the GLGI sequence present in the 5B1 construct; 
this domain, therefore, is not involved in the interaction with 
dystrophin. Instead, the syntrophin/dystrophin b ding could 
involve the conserved 56 carboxy-terminal residues pecific to 
the syntrophin family; we are currently testing this hypoth- 
esis. 
In conclusion, we have confirmed via an in vivo approach 
the direct interaction between dystrophin and ctl syntrophin 
and report he coding sequence of the human syntrophin gene, 
very well conserved with respect to the mouse and rabbit 
sequences. By pooling yeast DNA, we also propose a time- 
winning step to demonstrate he specificity of numerous posi- 
tive clones after a two-hybrid screen in yeast. The domain 
involved in the dystrophin/ctl syntrophin interaction is lo- 
cated at the distal half of syntrophin, a region particularly 
conserved among species and members of this family. 
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